Terms: = Head and neck cancer AND TGFBR2, AAT3, 7048, ENSG00000163513, P37173, TGFbeta-RII, RIIC, TAAD2, FAA3, TGFR-2, MFS2, HNPCC6 AND Diagnosis
2 results:
1. Methylation silencing of TGF-β receptor type II is involved in malignant transformation of esophageal squamous cell carcinoma.
Ma Y; He S; Gao A; Zhang Y; Zhu Q; Wang P; Yang B; Yin H; Li Y; Song J; Yue P; Li M; Zhang D; Liu Y; Wang X; Guo M; Jiao Y
Clin Epigenetics; 2020 Feb; 12(1):25. PubMed ID: 32046777
[TBL] [Abstract] [Full Text] [Related]
2. The early manifestation, tumor-specific occurrence and prognostic significance of tgfbr2 aberrant splicing in oral carcinoma.
Sivadas VP; Gulati S; Varghese BT; Balan A; Kannan S
Exp Cell Res; 2014 Sep; 327(1):156-62. PubMed ID: 24846200
[TBL] [Abstract] [Full Text] [Related]
